ENTRY       D02780                      Drug
NAME        Acamprosate calcium (JAN/USAN);
            Campral (TN);
            Regtect (TN)
PRODUCT
  GENERIC   ACAMPROSATE CALCIUM (American Health Packaging)
            ACAMPROSATE CALCIUM (Cadila Healthcare Limited)
            ACAMPROSATE CALCIUM (Glenmark Pharmaceuticals)
            ACAMPROSATE CALCIUM (Major Pharmaceuticals)
            ACAMPROSATE CALCIUM (Mylan Pharmaceuticals)
            ACAMPROSATE CALCIUM (Zydus Pharmaceuticals (USA))
FORMULA     (C5H10NO4S)2. Ca
EXACT_MASS  400.0287
MOL_WEIGHT  400.4824
CLASS       Neuropsychiatric agent
             DG01498  NMDA receptor antagonist
REMARK      Therapeutic category: 1190
            ATC code: N07BB03
            Chemical structure group: DG00996
            Product (DG00996): D02780<JP/US>
EFFICACY    Antialcohol dependence, NMDA receptor antagonist
  DISEASE   Alcohol dependence [DS:H01611]
COMMENT     Treatment of alcohol dependency
TARGET      GRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]
  PATHWAY   hsa04080(2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction
            hsa04724(2902+2903+2904+2905+2906)  Glutamatergic synapse
            hsa04728(2903+2904)  Dopaminergic synapse
            hsa05034(2902+2903+2904+2905+2906)  Alcoholism
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07B DRUGS USED IN ADDICTIVE DISORDERS
                N07BB Drugs used in alcohol dependence
                 N07BB03 Acamprosate
                  D02780  Acamprosate calcium (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anti-Addiction/Substance Abuse Treatment Agents
              Alcohol Deterrents/Anti-craving
               Acamprosate
                D02780  Acamprosate calcium (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D02780  Acamprosate calcium (JAN/USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01498  NMDA receptor antagonist
               DG00996  Acamprosate
                D02780  Acamprosate calcium
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               Glutamate (ionotropic), NMDA
                GRIN (NMDAR)
                 D02780  Acamprosate calcium (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02780
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02780
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02780
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01498  NMDA receptor antagonist
               DG00996  Acamprosate
DBLINKS     CAS: 77337-73-6
            PubChem: 17396938
            ChEBI: 51042
            LigandBox: D02780
            NIKKAJI: J309.378F
ATOM        23
            1   C1a C    21.6233  -20.9826
            2   C5a C    22.8217  -21.6744
            3   N1b N    24.0200  -20.9826
            4   C1b C    25.2183  -21.6744
            5   C1b C    26.4166  -20.9826
            6   C1b C    27.6150  -21.6744
            7   S4a S    28.8134  -20.9826
            8   O5a O    22.8217  -23.0582
            9   O1d O    30.0258  -21.6827 #-
            10  O1d O    30.0258  -20.2826
            11  O1d O    27.6009  -20.2826
            12  Z   Ca   34.4228  -22.0203 #2+
            13  C1a C    21.6233  -20.9826
            14  C5a C    22.8217  -21.6744
            15  N1b N    24.0200  -20.9826
            16  C1b C    25.2183  -21.6744
            17  C1b C    26.4166  -20.9826
            18  C1b C    27.6150  -21.6744
            19  S4a S    28.8134  -20.9826
            20  O1d O    30.0258  -21.6827 #-
            21  O1d O    30.0258  -20.2826
            22  O1d O    27.6009  -20.2826
            23  O5a O    22.8217  -23.0582
BOND        20
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     2   8 2
            8     7   9 1
            9     7  10 2
            10    7  11 2
            11   13  14 1
            12   14  15 1
            13   15  16 1
            14   16  17 1
            15   17  18 1
            16   18  19 1
            17   14  23 2
            18   19  20 1
            19   19  21 2
            20   19  22 2
BRACKET     1    19.7400  -24.0100   19.7400  -18.6200
            1    31.0800  -18.6200   31.0800  -24.0100
            1  2
  ORIGINAL  1    1   2   3   4   5   6   7   9  10  11   8
  REPEAT    1   13  14  15  16  17  18  19  20  21  22  23
///
